Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Nov 19;12(11):3541. doi: 10.3390/nu12113541

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Cytoplasmic and nuclear vitamin D receptor (VDR) immunostaining in normal ovary and ovarian tumors (n = 20) (A,B), in relation to tumors grade in primary tumors (n = 57) (C,D) and in metastatic tumors (n = 13) (E,F). Statistically significant differences are denoted with asterisks as determined by ANOVA (black asterisks) or Student’s t-test (red asterisks, * p < 0.05, ** p < 0.01, *** p < 0.001). (G) Representative VDR immunostaining in normal epithelia, ovarian cancers, and positive (POS CTRL) and negative (NEG CTRL) controls. Scale bars = 50 µm.

Cytoplasmic and nuclear vitamin D receptor (VDR) immunostaining in normal ovary and ovarian tumors (n = 20) (A,B), in relation to tumors grade in primary tumors (n = 57) (C,D) and in metastatic tumors (n = 13) (E,F). Statistically significant differences are denoted with asterisks as determined by ANOVA (black asterisks) or Student’s t-test (red asterisks, * p < 0.05, ** p < 0.01, *** p < 0.001). (G) Representative VDR immunostaining in normal epithelia, ovarian cancers, and positive (POS CTRL) and negative (NEG CTRL) controls. Scale bars = 50 µm.